⌕
GridAI Technologies · GRDX · Nasdaq
Tenet 26 · Weak
Compare
$3.45+2.68%At closeTenet 26 · Weak
$3.45+0.09 (+2.68%)
At close: Nov 19, 2026, 4:00 PM ET· Nasdaq · USD

GridAI Technologies (GRDX) Stock

GridAI Technologies (GRDX) closed at $3.45 on Nov 19, 2026; its Tenet Score is 26 of 100 against 486 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

Key stats

Close
$3.45
Nov 19, 2026
Market cap
$35.4M
share price × the latest quarter's diluted weighted-average share count (vendor)
52-week range
1.87 – 6.93
low → high
Tenet Score
26/100
Weak · 486 Healthcare peers

Industry: Drugs · see every company filed here →

GridAI Technologies Corp. scores 26/100. Weak. Quality is the soft spot versus 486 Healthcare peers. Insufficient inputs: Tenet 26 is built from 3 of 4 pillars, from 45% of its inputs. The pillars showing a dash had no data.

Tenet Score · vs sector

n=486
26/ 100
Weak
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
53
Quality
11
Health
14
Growth
—

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
Growth omitted — no data yet.
ValueCQualityFHealthFGrowth—MomentumC
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
Not meaningful: the company made a loss.
P/B
3.2×
cap ÷ Sep 30, 2026 book value, Nov 19, 2026 close
P/S
976.9×
price to sales
ROE
−107%
TTM through Sep 30, 2026
Operating margin
−19540.0%
fiscal 2025, before interest and tax
Net margin
—
Not reported in the company's filings for this period.
Current ratio
0.26
Sep 30, 2026 balance sheet
Net debt / EBITDA
—
Not meaningful: EBITDA is zero or negative.
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About GridAI Technologies Corp.

Entero Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of targeted and orally delivered therapies for the treatment of patients with gastrointestinal diseases. The company's pipeline candidates include latiglutenas…

Composite computed Nov 20, 2026 · peer basis: Healthcare (n=486) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 2 US ETFs · top wrappers by weightSee all ETFs holding GRDX →

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

What sector and industry is GridAI Technologies in?

GridAI Technologies is in the Healthcare sector and the Drugs industry.

What is GridAI Technologies' Tenet Score?

GridAI Technologies' Tenet Score is 26 out of 100, ranked against 486 Healthcare peers as of Nov 20, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.